{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Cargo Therapeutics, Inc.
Is Cargo Therapeutics, Inc. technically bullish or bearish?
As of June 20, 2025, the market trend is mildly bearish, indicated by daily moving averages and Dow Theory, despite mixed signals from the MACD and RSI across different time frames.
What does Cargo Therapeutics, Inc. do?
Cargo Therapeutics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting a recent net profit loss of $84 million and a market cap of $201.52 million. Key metrics include a negative P/E ratio, no dividend yield, and a return on equity of -60.15%.
How big is Cargo Therapeutics, Inc.?
As of Jun 18, Cargo Therapeutics, Inc. has a market capitalization of 201.52 million and reported net sales of 0.00 million with a net profit of -216.20 million over the latest four quarters. Shareholder's funds are at 360.23 million and total assets at 414.05 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
